Rchr
J-GLOBAL ID:201801001240291740   Update date: Feb. 01, 2024

Akihito Sawada

Akihito Sawada
Affiliation and department:
Research field  (1): Virology
Research theme for competitive and other funds  (3):
  • 2020 - 2023 RSV/麻疹キメラウイルスを用いた呼吸器感染症ワクチンの開発
  • 2016 - 2019 Development of new mumps vaccine induced by genomic recombinant virus vector system
  • 2016 - 2019 Immunogenic investigation of RSV/Measles chimeric virus
Papers (19):
  • Yuki Higashimoto, Kei Kozawa, Hiroki Miura, Yoshiki Kawamura, Masaru Ihira, Hiroyuki Hiramatsu, Ryota Suzuki, Kei Haga, Reiko Takai-Todaka, Akihito Sawada, et al. Correlation between anti-S IgG and neutralizing antibody titers against three live SARS-CoV-2 variants in BNT162b2 vaccine recipients. Human vaccines & immunotherapeutics. 2022. 18. 6. 2105611-2105611
  • Kentaro Mori, Takeaki Sasamoto, Tetsuo Nakayama, Shinichiro Morichi, Yasuyo Kashiwagi, Akihito Sawada, Hisashi Kawashima. Chemokine/Interleukin Imbalance Aggravates the Pathology of Respiratory Syncytial Virus Infection. Journal of clinical medicine. 2022. 11. 20
  • Kei Haga, Reiko Takai-Todaka, Akihito Sawada, Kazuhiko Katayama. Luciferase-based quantification of membrane fusion induced by SARS CoV2 S protein. Genes to cells : devoted to molecular & cellular mechanisms. 2022. 27. 8. 537-543
  • Kei Haga, Reiko Takai-Todaka, Yuta Matsumura, Chihong Song, Tomomi Takano, Takuto Tojo, Atsushi Nagami, Yuki Ishida, Hidekazu Masaki, Masayuki Tsuchiya, et al. Nasal delivery of single-domain antibody improves symptoms of SARS-CoV-2 infection in an animal model. PLoS pathogens. 2021. 17. 10. e1009542
  • Akihito Sawada, Takashi Ito, Yoshiaki Yamaji, Tetsuo Nakayama. Chimeric Measles Virus (MV/RSV), Having Ectodomains of Respiratory Syncytial Virus (RSV) F and G Proteins Instead of Measles Envelope Proteins, Induced Protective Antibodies against RSV. Vaccines. 2021. 9. 2
more...
MISC (5):
  • 澤田 成史, 伊藤 尚志, 中山 哲夫, 河島 尚志, 片山 和彦. コットンラットを用いた4種のRSV臨床分離株の病原性の検討. 臨床とウイルス. 2021. 49. 2. S65-S65
  • 森健太郎, 中山俊宏, 木村将裕, 森地振一郎, 柏木保代, 河島尚志, 澤田成史. RSウイルス感染症の重症化病態におけるケモカイン/サイトカインimbalanceの関与の検討. 日本化学療法学会雑誌. 2021. 69. Supplement-A
  • 森健太郎, 中山俊宏, 森地振一郎, 柏木保代, 河島尚志, 澤田成史. RSウイルス感染症におけるケモカインと重症化の検討. 小児感染免疫. 2021. 33. 3
  • 戸高 玲子, 芳賀 慧, 澤田 成史, 片山 和彦. 【新型コロナウイルス感染症】新型コロナウイルスに対する消毒薬の効果. 感染制御と予防衛生. 2020. 4. 1. 30-38
  • 木村将裕, 森地振一郎, 鈴木俊輔, 柏木保代, 河島尚志, 澤田成史. RSウイルス感染症におけるウイルス学的因子と重症化病態の検討. 臨床とウイルス. 2019. 47. 2. S73-S73
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page